A phase II study of a 3-day schedule with topotecan and cisplatin every three weeks in patients with previously in treated small cell lung cancer and extensive disease: Final results.

Research output: Contribution to journalConference articleResearchpeer-review

Original languageEnglish
JournalJournal of Clinical Oncology
Volume22
Issue number14
Pages (from-to)667S-667S
Number of pages1
ISSN0732-183X
Publication statusPublished - 15 Jul 2004
Event40th Annual Meeting of the American-Society-of-Clinical-Oncology - New Orleans, Lao People's Democratic Republic
Duration: 5 Jun 20048 Jun 2004

Conference

Conference40th Annual Meeting of the American-Society-of-Clinical-Oncology
CountryLao People's Democratic Republic
CityNew Orleans
Period05/06/200408/06/2004

ID: 335375655